Skip to content
Language
English
Chinese
Spanish
Search for:
Donate
Language
English
Chinese
Spanish
Search for:
Donate
Toggle Navigation
Facts
Symptoms
Statistics
Screening
Risk Factors
Genetics
Survival Rates
Glossary
Advocacy
Public Policy
Research Advocacy
Path to a Cure
Colorectal Cancer Care Initiative
Victories
Stories
Champion Stories
Ambassador Program
Strong Arm Selfie
Wall of Champions
Events
Host an Event
March Awareness
Call on Congress
Climb for a Cure
Colon Camp
Webinars
Resources
Blog
Guide in the Fight
Support
Resource Library
Provider Finder
Screening Quiz
Clinical Trial Finder
About
Our Mission
Our Team
Major Gifts
Financials
News & Press
Contact Us
TAKE ACTION
Take Action
Toggle Navigation
Facts
Symptoms
Statistics
Screening
Risk Factors
Genetics
Survival Rates
Glossary
Advocacy
Public Policy
Research Advocacy
Path to a Cure
Colorectal Cancer Care Initiative
Victories
Stories
Champion Stories
Ambassador Program
Strong Arm Selfie
Wall of Champions
Events
Host an Event
March Awareness
Call on Congress
Climb for a Cure
Colon Camp
Webinars
Resources
Blog
Guide in the Fight
Support
Resource Library
Provider Finder
Screening Quiz
Clinical Trial Finder
About
Our Mission
Our Team
Major Gifts
Financials
News & Press
Contact Us
TAKE ACTION
AZD5363+Olaparib+Durvalumab
Who we are
April 5, 2022
Phase I Study of AZD5363 + Olaparib + Durvalumab in Patients With Advanced or Metastatic Solid Tumor Malignancies
Discover the Art of Dance
Discover the Art of Dance
Whether you prefer ballet, jazz, or hip hop , we have a class for you.
View our dance classes
Page load link
